D.E. Shaw & Co
DRUG

D.E. Shaw & Co’s Bright Minds Biosciences DRUG Stock Holding History

D.E. Shaw & Co’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.13M Buy
15,445
+11,528
+294% +$928K ﹤0.01% 3362
2025
Q4 		$306K Buy
+3,917
New +$262K ﹤0.01% 4142

Other funds holding DRUG

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

D.E. Shaw & Co's DRUG Position: Q1 2026 in Review

D.E. Shaw & Co increased its Bright Minds Biosciences (DRUG) stake by 294% in Q1 2026, buying an estimated $928K and bringing the position to 15,445 shares worth $1.13M. The position accounts for ﹤0.01% of the portfolio, ranked #3362.

D.E. Shaw & Co first reported a position in DRUG in Q4 2025 and has held it in 2 quarters since. 94 funds tracked by Wall St. Rank hold DRUG as of Q1 2026.

  • D.E. Shaw & Co held 15,445 shares of Bright Minds Biosciences worth $1.13M as of Q1 2026.
  • D.E. Shaw & Co bought 11,528 Bright Minds Biosciences shares in Q1 2026, an estimated $928K.
  • Bright Minds Biosciences made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #3362 holding.
  • D.E. Shaw & Co first reported a position in Bright Minds Biosciences in Q4 2025 and has held it in 2 quarters since.
  • 94 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.